跳至主要内容
临床试验/ACTRN12618002009291
ACTRN12618002009291撤回未知

The role of mindfulness based stress reduction in restoring mood homeostasis and reducing symptoms of depression, stress and inflammation in patients with Crohn’s disease: An exploratory randomised control trial

Deakin University0 个研究点目标入组 40 人开始时间: 2018年12月14日最近更新:
适应症

试验速览

阶段
未知
状态
撤回
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1)A clinically established diagnosis of Crohn’s disease (per usual clinical practice in a tertiary care centre)
  • 2)Sufficient knowledge of English to understand the study instructions, answer the questionnaires and participate in the Mindfulness Based Stress Reduction group (MBSR). Note; as this is an exploratory study and involves a group intervention, it will not be possible to conduct the MBSR intervention in any language other than English.
  • 3)18 years of age or older
  • 4)Competence to consent
  • 5)Access to the internet by a smart phone and the willingness to download the Instant Survey app.
  • 6)A willingness to commit to 2.5 hours of MBSR at the identified times for a period of 8 consecutive or near-consecutive weeks, and engage with the homework sheets in the intervening period.
  • 7)Scores of depression at mild or moderate levels of the DASS scale

排除标准

  • 1)Alcohol/substance dependence, as identified by the gastroenterology team
  • 2)Severe mental illness (e.g. psychosis, schizophrenia), as identified by the gastroenterology team
  • 3)Severe anxiety or depressive symptoms as indicated by a scores >21 on the depression scale or > 15 on the anxiety scale of the DASS measure
  • 4)Significant cognitive impairment
  • 5)Inability to read or write
  • 6)Inability to speak or understand English (see note above)
  • 7)A regular (weekly or more often) mindfulness practice.

研究者

相似试验